Close

Sunesis Pharmaceuticals (SNSS) Misses Q2 EPS by 2c

July 30, 2015 7:04 AM EDT

Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $854 thousand versus the consensus estimate of $1.21 million.

For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings